Zobrazeno 1 - 10
of 36
pro vyhledávání: '"H. A. A. M. van Vliet"'
Autor:
S. I. Stegwee, I. P. M. Jordans, L. F. van der Voet, M. Y. Bongers, C. J. M. de Groot, C. B. Lambalk, R. A. de Leeuw, W. J. K. Hehenkamp, P. M. van de Ven, J. E. Bosmans, E. Pajkrt, E. A. Bakkum, C. M. Radder, M. Hemelaar, W. M. van Baal, H. Visser, J. O. E. H. van Laar, H. A. A. M. van Vliet, R. J. P. Rijnders, M. Sueters, C. A. H. Janssen, W. Hermes, A. H. Feitsma, K. Kapiteijn, H. C. J. Scheepers, J. Langenveld, K. de Boer, S. F. P. J. Coppus, D. H. Schippers, A. L. M. Oei, M. Kaplan, D. N. M. Papatsonis, L. H. M. de Vleeschouwer, E. van Beek, M. N. Bekker, A. J. M. Huisjes, W. J. Meijer, K. L. Deurloo, E. M. A. Boormans, H. W. F. van Eijndhoven, J. A. F. Huirne
Publikováno v:
BMC Pregnancy and Childbirth, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Double-layer compared to single-layer closure of the uterus after a caesarean section (CS) leads to a thicker myometrial layer at the site of the CS scar, also called residual myometrium thickness (RMT). It possibly decreases the
Externí odkaz:
https://doaj.org/article/1ea296b7f54f40efb530afe59fed14bd
Publikováno v:
Annals of Hematology
Dear Editor, Thrombotic thrombocytopenic purpura (TTP) is a rare disease, characterised by thrombocytopenia and microangiopathic haemolytic anaemia. Under normal circumstances, unusually large multimers (UL) of von Willebrand factor (VWF) are release
Autor:
Jan Rosing, F. R. Rosendaal, Svetlana N. Tchaikovski, Kathrin Fleischer, H. A. A. M. Van Vliet, Frans M. Helmerhorst
Publikováno v:
Thrombosis Research, 123(3), 429-435. Elsevier Ltd.
Introduction: The transdermal patch (20 mu g ethinylestradiol+150 mu g norelgestromin daily) and the vaginal ring (15 mu g ethinylestradiol+120 mu g etonogestrel daily) are new contraceptives, designed to deliver a tow dose of hormones, suggesting a
Autor:
F. R. Rosendaal, Anders E.A. Dahm, H. A. A. M. Van Vliet, R M Bertina, Frans M. Helmerhorst, P. Morten Sandset, Jan Rosing
Publikováno v:
Journal of Thrombosis and Haemostasis. 6:346-351
Summary. Background: Oral contraceptives (OC) containing different types of progestogens induce different sensitivities to activated protein C (APC) measured with the thrombin generation-based APC-resistance test. These differences in APC resistance
Autor:
M. Raps, Frans M. Helmerhorst, Joyce Curvers, Stella Thomassen, Bart E.P.B. Ballieux, Frits R. Rosendaal, H. A. A. M. Van Vliet, Jan Rosing
Publikováno v:
Thrombosis Research, 133(4), 640-644
Thrombosis Research, 133(4), 640-644. Elsevier Science
Thrombosis Research, 133(4), 640-644. Elsevier Science
Introduction Use of combined hormonal contraceptives is associated with a three- to eight-fold increased risk of venous thrombosis compared with non-use. The thrombotic risk depends on the estrogen dose as well as the progestogen type. Use of hormona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89a81d5f9ec066b7e380125669a40403
http://hdl.handle.net/1887/102595
http://hdl.handle.net/1887/102595
Autor:
J. J. Michiels, H. H. D. M. Van Vliet, F.J. Zijlstra, F. J. Prins, D. van de Moesdijk, U. Budde, P. J. J. Van Genderen, R. Van Strik
Publikováno v:
Annals of Hematology, 215-220. Springer-Verlag
ISSUE=75;STARTPAGE=215;ENDPAGE=220;ISSN=0939-5555;TITLE=Annals of Hematology
ISSUE=75;STARTPAGE=215;ENDPAGE=220;ISSN=0939-5555;TITLE=Annals of Hematology
Patients with essential thrombocythemia (ET), who frequently have bleeding complications, may manifest an excessive prolongation of the bleeding time (BT) after ingestion of aspirin (ASA). The reason for this excessive prolongation of the BT is unkno
Autor:
M, Raps, F M, Helmerhorst, K, Fleischer, A, van Hylckama Vlieg, V A, Van Hylckama, B H, Stegeman, S, Thomassen, F R, Rosendaal, J, Rosing, B E P B, Ballieux, H A A M, Van Vliet
Publikováno v:
Journal of Thrombosis and Haemostasis, 11, 396-7
Journal of Thrombosis and Haemostasis, 11, 2, pp. 396-7
Journal of Thrombosis and Haemostasis, 11, 2, pp. 396-7
Kluft et al. question the design of our recent study regarding Sex Hormone-Binding Globulin (SHBG) as marker for the risk of venous thrombosis during use of hormonal contraceptives (1). They state that when measured only in women 'on-treatment', SHBG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d16d4ee96b1707cd0cb370daacce745e
https://hdl.handle.net/1887/96902
https://hdl.handle.net/1887/96902
Autor:
Frans M. Helmerhorst, M. Raps, A. van Hylckama Vlieg, F. R. Rosendaal, B.H. Stegeman, Hans L. Vos, H. A. A. M. Van Vliet
Publikováno v:
Journal of Thrombosis and Haemostasis, 11(1), 203-5
The effect of a combined oral contraceptive (COC) on sex hormone binding globulin (SHBG) levels may be an indicator for venous thrombosis risk of the COC involved [12]. SHBG is a plasma glycoprotein primarily produced in hepatocytes that binds the se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::388f843808a110a9d86653f0ad10227d
https://doi.org/10.1111/jth.12054
https://doi.org/10.1111/jth.12054
Autor:
A. Hofman, H. H. D. M. Van Vliet, D.E. Grobbee, Michiel L. Bots, J.G. van der Bom, Huib A.P. Pols
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 16:864-867
Antithrombin is a potent inhibitor of thrombotic tendency. Whether atherosclerotic disease is associated with high or low antithrombin is unclear. Studies of the relation between antithrombin and presence of arterial disease have shown contrasting re
Autor:
H. H. D. M. Van Vliet, V. D. Vuzevski, P. J. J. Van Genderen, Jan Jacques Michiels, F. J. Prins, I. S. Lucas, R. Van Strik
Publikováno v:
Thrombosis and Haemostasis. 76:333-338
SummaryErythromelalgia, a characteristic aspirin-responsive microvascular thrombotic complication in essential thrombocythemia (ET), may develop despite oral anticoagulant treatment or treatment with heparin, suggesting that the generation of thrombi